Back to search results
NCT06601933

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Recruiting
PHASE2Ages 55–89InterventionalTreatment
Columbia University
~240 participants
Updated 2026-07-28 on ClinicalTrials.gov
What's tested:Cognitive Training

At a glance

Recruiting sites
4 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in ADASCog-14 (14-item Alzheimer's Disease Assessment Scale - Cognitive subscale)
Measured over Baseline, 78 weeks

Conditions

Mild Cognitive Impairment (MCI)
Cognitive Training

Explore related trials

Mild cognitive disorder

NCT06601933

Where you'd take part

This study runs at 4 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Columbia University Irving Medical Center

    New York, New Yorkstudy coordinator listed

    Recruiting

  • Duke University Medical Center

    Durham, North Carolinastudy coordinator listed

    Recruiting

  • University of Miami Miller School of Medicine

    Miami, Floridastudy coordinator listed

    Recruiting

  • University of Washington

    Seattle, Washingtonstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Lola Nedic, BA
[email protected]
6467747202
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Change in ADASCog-14 (14-item Alzheimer's Disease Assessment Scale - Cognitive subscale)Baseline, 78 weeks

    The ADASCog-14 is a brief neuropsychological assessment used to assess the severity of cognitive symptoms of dementia. It is one of the most widely used cognitive scales in clinical trials and is considered to be the "gold standard" for assessing antidementia treatments. The total score range is 0 to 90; a higher score indicates greater cognitive impairment.